- Supported exchanges /
- SHG /
- 688247.SHG
Sinotherapeutics Inc. A (688247 SHG) stock market data APIs
Sinotherapeutics Inc., a specialty pharmaceutical company, develops generic and formulation products in China. It offers posaconazole delayed-release tablets, ursodeoxycholic acid capsules, bupropion hydrochloride extended-release tablets, paroxetine extended-release tablets, sevelamer carbonate tablets, and propafenone hydrochloride extended-release capsules. The company provides CRO/CDMO services including pre-formulation study, formulation and process development, clinical sample manufacturing, NDA registration batch manufacturing, quality standard establishment, and regulatory dossier document preparation and submission. Sinotherapeutics Inc. was founded in 2012 and is headquartered in Shanghai, China.
Sinotherapeutics Inc. A Financial Data Overview
| 9.13 | |
| 9.54 | |
| - | |
| 9.54 | |
| 9.03 | |
| 6.2688-12.5973 | |
| 4 139 M | |
| 45.65 | |
| 453 M | |
| 407 M | |
| 0.017 | |
| 0.0045 | |
| 0.179 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Sinotherapeutics Inc. A Fundamental Data is available in our Financial Data APIs
- Net Revenue 407 M
- EBITDA 92 373 K
- Earnings Per Share 0.2
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Sinotherapeutics Inc. A Earnings via APIs
- Latest Release 2023-03-31
- EPS/Forecast NaN
Get Sinotherapeutics Inc. A End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
